HeartBeam, Inc.

As of June 18, 2025, the market trend has shifted to bearish, supported by negative signals from MACD, Bollinger Bands, and daily moving averages, despite some mildly bullish indicators from KST and Dow Theory.

HeartBeam, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $5 million and a market cap of $52.41 million. Key financial metrics include a negative P/E ratio, a 0.00% dividend yield, and a debt-to-equity ratio of -1.08.

As of Jun 18, HeartBeam, Inc. has a market capitalization of 52.41 million, with net sales of 0.00 million and a net profit of -20.33 million over the latest four quarters. Shareholder's funds are 1.65 million and total assets are 3.28 million.